Porcine Reproductive & Respiratory Syndrome roadmap:
Vaccines
Roadmap for development of a candidate vaccine for PRRSV
Download PRRSV Vaccine Roadmap9
Adjuvant
Dependencies
- 10 Expression system
- 12 Identity of virulence factors
Next steps
- 4 Inactivated vaccines
- 4A Safety
- 4B Delivery route
- 4C Delivery platform
- 4D Efficacy in challenge model
- 5 DNA/RNA vaccines
- 5A Safety
- 5B Delivery route
- 5C Delivery platform
- 5D Efficacy in challenge model
- 6 Subunit vaccines
- 6A Safety
- 6B Delivery route
- 6C Delivery platform
- 6D Efficacy in challenge model
Identifying suitable delivery systems for subunit and inactivated whole virus vaccine candidates
Research Question
- Generate an optimal immune response to the various vaccine candidates resulting in sterile immunity to wild type virus
Research Gaps and Challenges
- Generating both a strong VN Ab and a CTC response
Solution Routes
- Immune response to antigens delivered on nanoparticles
- Immune response following inclusion of various adjuvants with the candidate vaccines
Dependencies
- Identity of protective antigens
Projects
What activities are planned or underway?
Immune responses induced by inactivated Porcine Reproductive and Respiratory Syndrome Virus (PRRSV) vaccine in neonate pigs using different adjuvants
Planned Completion date 01/02/2021
Source Countries:
Netherlands
Additional file 1 of Analysis of ORF5 sequences of Porcine Reproductive and Respiratory Syndrome virus (PRRSV) circulating within swine farms in Costa Rica
Planned Completion date 01/01/2021
Source Countries:
Netherlands